CHICAGO (Reuters) - A new drug for the most common form of leukemia in adults improves survival for patients whose disease has worsened despite standard treatment, according to late-stage study findings released on Saturday. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/M4R7C9OtPAA/story01.htm
Read More
No comments:
Post a Comment